Cite

HARVARD Citation

    Tedeschi, A. et al. (n.d.). Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia. Leukemia & lymphoma. 56 (9), pp. 2637-2642. [Online]. 
  
Back to record